Ocular Inflammation and Choroidal Thickness after Pars Plana Vitrectomy in Chronic Recurrent Stage of Vogt-Koyanagi-Harada Disease

REFERENCES

• Moorthy RS, Inomata H, Rao NA. Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol. 1995;39(4):265–292. doi:10.1016/s0039-6257(05)80105-5.
   PubMed Web of Science ®Google Scholar
• Herbort CP Jr., Abu El Asrar AM, Yamamoto JH, et al. Reappraisal of the management of Vogt-Koyanagi-Harada disease: sunset glow fundus is no more a fatality. Int Ophthalmol. 2017;37(6):1383–1395. doi:10.1007/s10792-016-0395-0.
   PubMed Web of Science ®Google Scholar
• Park UC, Cho IH, Lee EK, Yu HG. The effect on choroidal changes of the route of systemic corticosteroids in acute Vogt-Koyanagi-Harada disease. Graefes Arch Clin Exp Ophthalmol. 2017;255(6):1203–1211. doi:10.1007/s00417-017-3654-5.
   PubMed Web of Science ®Google Scholar
• Takahashi H, Takase H, Ishizuka A, et al. Choroidal thickness in convalescent Vogt-Koyanagi-Harada disease. Retina. 2014;34(4):775–780. doi:10.1097/IAE.0b013e3182a6b3f6.
   PubMed Web of Science ®Google Scholar
• Lee EK, Lee SY, Yu HG. A clinical grading system based on ultra-wide field retinal imaging for sunset glow fundus in Vogt-Koyanagi-Harada disease. Graefes Arch Clin Exp Ophthalmol. 2015;253(3):359–368. doi:10.1007/s00417-014-2710-7.
   PubMed Web of Science ®Google Scholar
• Tagawa Y, Namba K, Mizuuchi K, et al. Choroidal thickening prior to anterior recurrence in patients with Vogt-Koyanagi-Harada disease. Br J Ophthalmol. 2016;100(4):473–477. doi:10.1136/bjophthalmol-2014-306439.
   PubMed Web of Science ®Google Scholar
• Read RW, Rechodouni A, Butani N, et al. Complications and prognostic factors in Vogt-Koyanagi-Harada disease. Am J Ophthalmol. 2001;131(5):599–606. doi:10.1016/s0002-9394(01)00937-0.
   PubMed Web of Science ®Google Scholar
• Arevalo JF, Lasave AF, Gupta V, et al. Clinical outcomes of patients with Vogt-Koyanagi-Harada disease over 12 years at a tertiary center. Ocul Immunol Inflamm. 2016;24(5):521–529. doi:10.3109/09273948.2015.1025984.
   PubMed Web of Science ®Google Scholar
• Coupland SE. The pathologist’s perspective on vitreous opacities. Eye (Lond). 2008;22(10):1318–1329. doi:10.1038/eye.2008.31.
   PubMed Web of Science ®Google Scholar
• O’Keefe GA, Rao NA. Vogt-Koyanagi-Harada disease. Surv Ophthalmol. 2017;62(1):1–25. doi:10.1016/j.survophthal.2016.05.002.
   PubMed Web of Science ®Google Scholar
• Kobayashi I, Inoue M, Okada AA, Keino H, Wakabayashi T, Kirakata A. Vitreous surgery for macular hole in patients with Vogt-Koyanagi-Harada disease. Clin Exp Ophthalmol. 2008;36(9):861–864. doi:10.1111/j.1442-9071.2008.01903.x.
   PubMed Web of Science ®Google Scholar
• Becker M, Davis J. Vitrectomy in the treatment of uveitis. Am J Ophthalmol. 2005;140(6):1096–1105. doi:10.1016/j.ajo.2005.07.017.
   PubMed Web of Science ®Google Scholar
• Henry CR, Becker MD, Yang Y, Davis JL. Pars plana vitrectomy for the treatment of uveitis. Am J Ophthalmol. 2018;190:142–149. doi:10.1016/j.ajo.2018.03.031.
   PubMed Web of Science ®Google Scholar
• Read RW, Holland GN, Rao NA, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol. 2001;131(5):647–652. doi:10.1016/s0002-9394(01)00925-4.
   PubMed Web of Science ®Google Scholar
• Chan CC, Matteson DM, Li Q, Whitcup SM, Nussenblatt RB. Apoptosis in patients with posterior uveitis. Arch Ophthalmol. 1997;115(12):1559–1567. doi:10.1001/archopht.1997.01100160729010.
   PubMedGoogle Scholar
• Kaplan HJ, Waldrep JC, Chan WC, Nicholson JK, Wright JD. Human sympathetic ophthalmia. Immunologic analysis of the vitreous and uvea. Arch Ophthalmol. 1986;104(2):240–244. doi:10.1001/archopht.1986.01050140094028.
   PubMedGoogle Scholar
• Ieki Y, Kiryu J, Kita M, et al. Pars plana vitrectomy for vitreous opacity associated with ocular sarcoidosis resistant to medical treatment. Ocul Immunol Inflamm. 2004;12(1):35–43.
   PubMed Web of Science ®Google Scholar
• Mizuno M, Fujinami K, Watanabe K, Akiyama K. Macular hole associated with Vogt-Koyanagi-Harada disease at the acute uveitic stage. Case Rep Ophthalmol. 2015;6(3):328–332. doi:10.1159/000440679.
   PubMed Web of Science ®Google Scholar
• Navarro RM, Guizilini GC, Machado LM, Maia M. Managing macular hole associated with acute inflammatory Vogt-Koyanagi-Harada syndrome. Int J Retina Vitreous. 2015;1:18. doi:10.1186/s40942-015-0020-9.
   PubMedGoogle Scholar
• Woo SJ, Yu HG, Chung H. Surgical outcome of vitrectomy for macular hole secondary to uveitis. Acta Ophthalmol. 2010;88(7):e287–288. doi:10.1111/j.1755-3768.2009.01667.x.
   PubMed Web of Science ®Google Scholar
• Ahn JK, Chung H, Yu HG. Vitrectomy for persistent panuveitis in Behcet’s disease. Ocul Immunol Inflamm. 2005;13(6):447–453. doi:10.1080/09273940591004232.
   PubMed Web of Science ®Google Scholar
• Shin YU, Shin JY, Ma DJ, Cho H, Yu HG. Preoperative inflammatory control and surgical outcome of vitrectomy in intermediate uveitis. J Ophthalmol. 2017;2017:5946240.
   PubMed Web of Science ®Google Scholar
• Takayama K, Tanaka A, Shibata M, et al. Evaluation of microincision vitrectomy surgery using wide-viewing system for complications with ocular sarcoidosis. Medicine (Baltimore). 2015;94(7):e559. doi:10.1097/MD.0000000000000874.
   PubMed Web of Science ®Google Scholar
• Ahn SJ, Woo SJ, Park KH. Choroidal thickness change following vitrectomy in idiopathic epiretinal membrane and macular hole. Graefes Arch Clin Exp Ophthalmol. 2016;254(6):1059–1067. doi:10.1007/s00417-015-3154-4.
   PubMed Web of Science ®Google Scholar
• Jap A, Chee SP. The role of enhanced depth imaging optical coherence tomography in chronic Vogt-Koyanagi-Harada disease. Br J Ophthalmol. 2017;101(2):186–189. doi:10.1136/bjophthalmol-2015-308091.
   PubMed Web of Science ®Google Scholar
• Margolis R, Spaide RF. A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. Am J Ophthalmol. 2009;147(5):811–815. doi:10.1016/j.ajo.2008.12.008.
   PubMed Web of Science ®Google Scholar
• Wei WB, Xu L, Jonas JB, et al. Subfoveal choroidal thickness: the Beijing eye study. Ophthalmology. 2013;120(1):175–180. doi:10.1016/j.ophtha.2012.07.048.
   PubMed Web of Science ®Google Scholar
• Nazari H, Hariri A, Hu Z, Ouyang Y, Sadda S, Rao NA. Choroidal atrophy and loss of choriocapillaris in convalescent stage of Vogt-Koyanagi-Harada disease: in vivo documentation. J Ophthalmic Inflamm Infect. 2014;4:9. doi:10.1186/1869-5760-4-9.
   PubMedGoogle Scholar
• Ji Y, Hu K, Li C, et al. Outcome and prognostic factors of phacoemulsification cataract surgery in Vogt-Koyanagi-Harada uveitis. Am J Ophthalmol. 2018;196:121–128. doi:10.1016/j.ajo.2018.08.041.
   PubMed Web of Science ®Google Scholar